Humacyte, Inc. short interest in 2025
In 2025, Humacyte, Inc.'s disclosed short interest ran from 20.37% of shares outstanding on 15 Jan 2025 to 19.41% on 31 Dec 2025, a change of -0.96 percentage points. The year's high was 21.69% on 15 Sep 2025 and its low 16.22% on 30 Apr 2025, averaging 19.38% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.33 days on 14 Feb 2025. Full history: Humacyte, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 20.37% (15 Jan 2025)
- End of year
- 19.41% (31 Dec 2025)
- Change
- -0.96 pp
- High
- 21.69% (15 Sep 2025)
- Low
- 16.22% (30 Apr 2025)
- Average
- 19.38%
- Highest days to cover
- 15.33 (14 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 20.37% | 7.32 | |
| 31 Jan 2025 | 19.10% | 13.80 | |
| 14 Feb 2025 | 19.13% | 15.33 | |
| 28 Feb 2025 | 20.24% | 10.49 | |
| 14 Mar 2025 | 21.14% | 12.25 | |
| 31 Mar 2025 | 17.49% | 4.27 | results (8-K), 10-K filed |
| 15 Apr 2025 | 16.82% | 4.58 | |
| 30 Apr 2025 | 16.22% | 10.64 | |
| 15 May 2025 | 19.57% | 6.08 | 10-Q filed, results (8-K) |
| 30 May 2025 | 20.50% | 5.85 | |
| 13 Jun 2025 | 18.33% | 6.64 | |
| 30 Jun 2025 | 19.71% | 12.26 | |
| 15 Jul 2025 | 21.09% | 7.67 | |
| 31 Jul 2025 | 20.55% | 7.88 | |
| 15 Aug 2025 | 21.63% | 4.64 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 21.22% | 7.99 | |
| 15 Sep 2025 | 21.69% | 14.92 | |
| 30 Sep 2025 | 18.18% | 7.44 | |
| 15 Oct 2025 | 17.19% | 2.63 | |
| 31 Oct 2025 | 20.36% | 7.83 | |
| 14 Nov 2025 | 17.84% | 6.29 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 18.50% | 7.31 | |
| 15 Dec 2025 | 18.90% | 9.26 | |
| 31 Dec 2025 | 19.41% | 6.47 |
See also: Humacyte, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.